Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | TOP1 | P11387 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL18640766 | 0.86 | LMNA (0.41) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL27291420 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL25934670 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL120420 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL21901457 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL25394654 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL27291406 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL4754912 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL22961915 | 0.82 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL4537848 | 0.80 | LMNA (0.55) | LMNAL3MBTL1TDP1TOP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6178 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117623991-A | Polysubstituted aryl cyclopropylamine urea compound, preparation method and application thereof | 上海爱博医药科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2023107653-A2 | BENZOFURAN SALT MORPHIC FORMS AND MIXTURES FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT | TACTOGEN INC (US) | 2023-06-15 | — | — | WO | claimed |
| EP-3216793-B1 | TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS | WYETH LLC (US) | 2019-03-27 | — | — | EP | claimed |
| EP-1787984-B1 | AZACYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF SEROTONIN RELATED DISEASES | ACADIA PHARM INC (US) | 2016-10-19 | — | — | EP | claimed |
| US-9238653-B2 | Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-01-19 | — | — | US | claimed |
| US-9174963-B2 | Triazine compounds as PI3 kinase and MTOR inhibitors | PFIZER INC. (US) | 2015-11-03 | — | — | US | claimed |
| US-20150011752-A1 | TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS | WYETH LLC | 2015-01-08 | — | — | US | claimed |
| EP-2483274-B1 | ANTIMALARIAL AGENTS THAT ARE INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE | UNIV TEXAS (US) | 2014-10-29 | — | — | EP | claimed |
| US-20120302586-A1 | ANTIMALARIAL AGENTS THAT ARE INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-11-29 | — | — | US | claimed |
| US-20110082150-A1 | Headache pre-emption by dihydroergotamine treatment during headache Precursor events | MAP PHARMACEUTICALS, INC. | 2011-04-07 | — | — | US | claimed |
| US-20090131326-A1 | ABUSE-RESISTANT AMPHETAMINE PRODRUGS | SHIRE LLC (US) | 2009-05-21 | — | — | US | claimed |
| WO-2006082108-A2 | IMAGING METHOD AND COMPOSITION FOR IMAGING VASCULAR DISEASES | SCHERING AG (DE) | 2006-08-10 | — | — | WO | claimed |
| EP-1311499-B1 | BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS | ORTHO MCNEIL PHARM INC (US) | 2006-04-12 | — | — | EP | claimed |
| EP-4731657-A2 | TRANSFERRIN RECEPTOR-BINDING MOLECULES, CONJUGATES THEREOF AND THEIR USES TO PREVENT OR TREAT MUSCULAR DISEASES | Vect-Horus (FR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731658-A1 | TRANSFERRIN RECEPTOR-BINDING MOLECULES, CONJUGATES THEREOF AND THEIR USES TO PREVENT OR TREAT NERVOUS SYSTEM DISEASES | Vect-Horus (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-12465660-B2 | Compositions and methods for cancer imaging and radiotherapy | VECT-HORUS (FR) | 2025-11-11 | — | — | US | disclosed |
| WO-1995014025-A1 | PIPERIDINYLCAMPHORSULFONYL OXYTOCIN ANTAGONISTS | MERCK & CO., INC. (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995002405-A1 | BENZOXAZINONE AND BENZOPYRIMIDINONE PIPERIDINYL TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1995-01-26 | — | — | WO | disclosed |
| WO-1994020104-A1 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO, INC. (US) | 1994-09-15 | — | — | WO | disclosed |
| EP-0532097-A1 | Piperazinyl(sulfon)amide derivatives of camphor as oxytocin antagonists | MERCK & CO. INC. (US) | 1993-03-17 | — | — | EP | disclosed |